Is ERYP or QYLD a better dividend investment in 2026?

ERYP currently yields 256.41% with a 5% 5-year dividend growth rate. QYLD yields 11.92% with -2.1% growth. The better choice depends on your goal: ERYP offers higher current income.

What is the dividend yield difference between ERYP and QYLD?

ERYP has a forward dividend yield of 256.41% ($2.00/share annually). QYLD yields 11.92% ($2.04/share annually). The yield gap is 244.49 percentage points.

Home › Compare › ERYP vs QYLD

ERYP vs QYLD: Dividend Comparison 2026

ERYP yields 256.41% · QYLD yields 11.92%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ERYP wins by $541.20M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ERYP

● Live price

256.41%

Share price

$0.78

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$541.22M

Annual income

$306,262,465.48

Full ERYP calculator →

QYLD

Global X Nasdaq 100 Covered Call ETF

● Live price

11.92%

Share price

$17.15

Annual div

$2.04

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.4K

Annual income

$5,659.31

Full QYLD calculator →

Portfolio growth — ERYP vs QYLD

📍 ERYP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ERYP	QYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ERYP + QYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ERYP pays

QYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ERYP

Annual income on $10K today (after 15% tax)

$21,794.87/yr

After 10yr DRIP, annual income (after tax)

$260,323,095.66/yr

QYLD

Annual income on $10K today (after 15% tax)

$1,013.51/yr

After 10yr DRIP, annual income (after tax)

$4,810.41/yr

At 15% tax rate, ERYP beats the other by $260,318,285.24/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ERYP + QYLD for your $10,000?

ERYP: 50%QYLD: 50%

100% QYLD50/50100% ERYP

Portfolio after 10yr

$270.62M

Annual income

$153,134,062.40/yr

Blended yield

56.59%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on ERYP right now

ERYP

Analyst Ratings

Buy

Consensus: Buy

Altman Z

1.9

Piotroski

2/9

QYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ERYP buys

QYLD buys

Politician	Chamber	Ticker	Type	Amount	Date
Tim Moore	🏢 House	$QYLD	▼ Sell	$15,001 - $50,000	2025-05-02
Tim Moore	🏢 House	$QYLD	▲ Buy	$15,001 - $50,000	2025-04-07
Dwight Evans	🏢 House	$QYLD	▼ Sell	$1,001 - $15,000	2022-11-14
Dwight Evans	🏢 House	$QYLD	▼ Sell	$1,001 - $15,000	2020-10-29

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricERYPQYLD

Forward yield	256.41% ✓	11.92%
Annual dividend / share	$2.00	$2.04 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$541.22M ✓	$25.4K
Annual income after 10y	$306,262,465.48 ✓	$5,659.31
Total dividends collected	$516.37M ✓	$27.1K
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: ERYP vs QYLD ($10,000, DRIP)

Year	ERYP Portfolio	ERYP Income/yr	QYLD Portfolio	QYLD Income/yr	Gap
1← crossover	$36,341	$25,641.03	$10,352	$1,192.36	+$26.0K → ERYP
2	$125,971	$87,086.09	$10,830	$1,347.57	+$115.1K → ERYP
3	$416,912	$282,122.92	$11,460	$1,539.07	+$405.5K → ERYP
4	$1,318,722	$872,626.36	$12,275	$1,777.84	+$1.31M → ERYP
5	$3,990,640	$2,579,607.07	$13,323	$2,078.95	+$3.98M → ERYP
6	$11,565,551	$7,295,566.53	$14,667	$2,463.34	+$11.55M → ERYP
7	$32,135,691	$19,760,551.21	$16,396	$2,960.57	+$32.12M → ERYP
8	$85,699,274	$51,314,084.97	$18,631	$3,612.97	+$85.68M → ERYP
9	$219,589,910	$127,891,686.63	$21,548	$4,482.15	+$219.57M → ERYP
10	$541,223,669	$306,262,465.48	$25,398	$5,659.31	+$541.20M → ERYP

ERYP vs QYLD: Complete Analysis 2026

ERYP — Stock

ERYTECH Pharma S.A., a clinical-stage biopharmaceutical company, develops red blood cell-based therapeutics for cancer and orphan diseases in France and the United States. Its lead product candidate is eryaspase, which is in Phase 3 clinical development for the treatment of second-line pancreatic cancer, and in Phase 2 stage for the treatment of triple-negative breast cancer and second-line acute lymphoblastic leukemia patients. The company also engages in developing erymethionase, a preclinical product candidate that consists of methionine-?-lyase in red blood cells to target methionine cancers. The company was incorporated in 2004 and is headquartered in Lyon, France.

Full ERYP Calculator →

QYLD — ETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →

📬

Get this ERYP vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ERYP vs SCHD ERYP vs JEPI ERYP vs O ERYP vs KO ERYP vs MAIN ERYP vs XYLD ERYP vs JEPQ ERYP vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.